ONN^® - OncLive News Network^®

Bhavana Pothuri, MD, and Tiffany Redfern, MD, FACOG, break down the latest data trends in platinum-resistant ovarian cancer.

Christian Marth, MD, PhD, and John Chan, MD, discuss the latest data trends in advanced endometrial cancer.

Daniel J. George, MD, and Matthew Smith, MD, PhD, discuss updates in the metastatic hormone-sensistive prostate cancer realm.

Floortje J Backes, MD, discusses evolving treatment considerations for platinum-resistant ovarian cancer.

George Yaghmour, MD, and Rachel Elizabeth Rau, MD, discuss updates in acute lymphoblastic leukemia following ASH 2024.

Sangeetha Venugopal, MD, MS, discusses treatment trends and emerging data in the management of myelofibrosis.

Grzegorz S. Nowakowski, MD, and Samuel Yamshon, MD, discuss key updates in the follicular lymphoma field following the 2024 ASH Annual Meeting

Amer Zeidan, MBBS, and Guillermo Garcia-Manero, MD, highlight treatment trends and key data emerging in the field of myelodysplastic syndromes.

Javier Pinilla, MD, PhD, and Talha Badar, MBBS, MD, discuss key data updates and trends in chronic myeloid leukemia after ASH 2024.

OncLive® will be premiering OncLive® News Network: On Location at the 2024 San Antonio Breast Cancer Symposium! Each day, we will broadcast a series of interviews with top thought leaders, to learn their thoughts and reactions to data presented across oncology during the conference.

OncLive® will be premiering OncLive® News Network: On Location at the 2024 ASH Annual Meeting! Each day, we will broadcast a series of interviews with top thought leaders, to learn their thoughts and reactions to data presented across oncology during the conference.

Jessica Donington, MD, MSCR, Melina Elpi Marmarelis, MD, and Ibiayi Dagogo-Jack, MD, discuss biomarker testing in non–small cell lung cancer.

Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss updates in HCC and GI cancers from the 2024 ESMO Congress.

Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, discuss updates in ALK-positive and ROS1-positive non–small cell lung cancer.

James K. McCloskey, MD, and Harry P. Erba, MD, PhD, discuss updates in acute myeloid leukemia following the 2024 SOHO Annual Meeting.

Yoshiaki Nakamura, MD, PhD, discusses how a methylation-based circulating tumor DNA assay can enhance minimal residual disease detection and improve prognosis in patients with previously treated stage II-III colorectal cancer.

Samuel Cytryn, MD, and David B. Zhen, MD, on updates in gastrointestinal cancers from the 2024 ASCO Annual Meeting and Gastrointestinal Cancers Symposium.

Marc S. Hoffmann, MD, and Mazyar Shadman, MD, MPH, discuss the real-world use of BTK inhibitors for patients with chronic lymphocytic leukemia.

Joyce A. O’Shaughnessy, MD, and Neil M. Iyengar, MD, discuss the changing treatment landscape of patients with advanced or metastatic HER2-positive breast cancer.

Ibrahim T. Aldoss, MD; and Elias Jabbour, MD, discuss updates to the treatment paradigm of Philadelphia chromosome–positive acute lymphoblastic leukemia.